Lexaria Bioscience Stock Forum

$Lexaria Bioscience (LEXX.US)$ 1.4 or more eod

$Lexaria Bioscience (LEXX.US)$ why offering so low? $1 ? come on anyone should be paying $1.5 this is a 50MM MC company!!! only on potential, if and big IF hit a partnership w some big pharma we can see a MC of 500MM or more!

$Lexaria Bioscience (LEXX.US)$
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology
Wednesday, 23rd April at 9:10 am
Pfizer and Eli Lilly reporting significant - and opposing - news in the GLP-1 industry
Lexaria's technology could enhance performance and lower side effects
KELOWNA, BC / ACCESS Newswire / April 23, 2025 / Lexaria Bioscience Corp. (NASDAQ: LEXX)(NASDAQ: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, ...

$Lexaria Bioscience (LEXX.US)$ llily pill looks promising this should impact lexx.

$Lexaria Bioscience (LEXX.US)$ when NR about partnership hit we gonna see $5 at least imho. GLTA.

$Lexaria Bioscience (LEXX.US)$
Lexaria's GLP-1 Study Hits Major Milestone with 20% Higher Patient Enrollment

$Lexaria Bioscience (LEXX.US)$ we need THE NR asap.

$Lexaria Bioscience (LEXX.US)$ most of sale on march 18 was short, let see how they cover...

$Lexaria Bioscience (LEXX.US)$
Revolutionary Oral Alternative to Zepbound Shows 47% Fewer Side Effects in Clinical Trial

$Lexaria Bioscience (LEXX.US)$
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound(R)
Tuesday, 18th March at 9:15 am
More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®
As previously announced, oral DehydraTECH-tirzepatide also reduced adverse events by 47% compared to injected Zepbound®
...